Repository logoRepository logo
GRO
  • GRO.data
  • GRO.plan
Help
  • English
  • Deutsch
Log In
New user? Click here to register.Have you forgotten your password?
Publications
Researcher
Organizations
Other
  • Journals
  • Series
  • Events
  • Projects
  • Working Groups

Browsing by Author "Weis, C.-A."

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Some of the metrics are blocked by your 
    consent settings
    Angiotensin II-induces activation of RhoA via an AT(1)R-, G(q/11)- and p63RhoGEF-dependent pathway in caveolae of neonatal cardiac fibroblasts
    (Springer, 2011)
    Weis, C.-A.
    ;
    Vettel, Christiane  
    ;
    Wuertz, Christina  
    ;
    Wieland, Thomas
    ;
    Lutz, S.
  • Some of the metrics are blocked by your 
    consent settings
    The expression and secretion of the connective tissue growth factor in cardiac fibroblasts is controlled through the RhoA signaling axis
    (Springer, 2011)
    Wuertz, Christina  
    ;
    Weis, C.-A.
    ;
    Vettel, Christiane  
    ;
    Nowak, K.
    ;
    Otte, K.
    ;
    Ewens, S.
    ;
    Tiburcy, Malte  
    ;
    Schubert, P.
    ;
    Zimmermann, Wolfram-Hubertus  
    ;
    Wieland, Thomas
    ;
    Lutz, S.
  • Some of the metrics are blocked by your 
    consent settings
    Thymic carcinomas
    (Springer, 2016)
    Stroebel, Philipp  
    ;
    Weis, C.-A.
    ;
    Marx, A.
    Thymic carcinomas (TC) are approximately 10 times less prevalent than thymomas but of high clinical relevance because they are more aggressive, less frequently resectable than thymomas and usually refractory to classical and targeted long-term treatment approaches. Furthermore, in children and adolescents TC are more frequent than thymomas and particularly in this age group, germ cell tumors need to be a differential diagnostic consideration. In diagnostic terms pathologists face two challenges: a), the distinction between thymic carcinomas and thymomas with a similar appearance and b), the distinction between TC and histologically similar metastases and tumor extensions from other primary tumors. Overcoming these diagnostic challenges is the focus of the new WHO classification of thymic epithelial tumors. The objectives of this review are to highlight novel aspects of the WHO classification of thymic carcinomas and to address therapeutically relevant diagnostic pitfalls.
  • Some of the metrics are blocked by your 
    consent settings
    Thymomas
    (Springer, 2016)
    Marx, A.
    ;
    Weis, C.-A.
    ;
    Stroebel, Philipp  
    Thymomas are rare tumors but are one of the most common mediastinal neoplasms in adults and exhibit an enormous variability in histological, biological and genetic features. The morphological spectrum within a given entity is enormous and some tumors with histological patterns of more than one entity are more common than pure histological subtypes. Due to a lack of subtype-specific markers classification of thymomas often requires complex diagnostic algorithms. The refined presentation including the definition of obligatory and optional features and of diagnostic immunohistochemical profiles, is the focus of the new World Health Organization (WHO) classification of thymomas, aiming at improving diagnostic reproducibility. This review highlights novel aspects of the WHO classification of thymomas and addresses typical differential diagnostic challenges with a focus on diagnostic pitfalls.

About

About Us
FAQ
ORCID
End User Agreement
Privacy policy
Cookie consent
Imprint

Contact

Team GRO.publications
support-gro.publications@uni-goettingen.de
Matrix Chat: #support_gro_publications
Feedback

Göttingen Research Online

Göttingen Research Online bundles various services for Göttingen researchers:

GRO.data (research data repository)
GRO.plan (data management planning)
GRO.publications (publication data repository)
Logo Uni Göttingen
Logo Campus Göttingen
Logo SUB Göttingen
Logo eResearch Alliance

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.